Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid for Complications After Cardiac Surgery
NCT05690646Phase 4Completed
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Jan 2023
- Primary completion
- Mar 2023
- Modality
- Modified Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of nirmatrelvir + ritonavir, ursodeoxycholic acid in postoperative complications, sponsored by National Center for Cardiovascular Disease. Started Jan 2023; status: completed.
02
Drugs
nirmatrelvir + ritonavirursodeoxycholic acid
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT05690646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05690646.